Bevacizumab, with Sorafenib and Cyclophosphamide Provides Clinical Benefit for Recurrent or Refractory Osseous Sarcomas in Children and Young Adults
FRONTIERS IN ONCOLOGY（2022）
关键词
pediatric sarcomas,Ewing sarcoma,osteosarcoma,sorafenib,cyclophosphamide,anti-angiogeneic therapy,bevacizumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要